provided by circulating
monocytes and tumor-associated macrophages (TAMs). We highlight that
monocytePiatnitskaia, Svetlana,
Rafikova, Guzel,
Bilyalov, Azat,
Chugunov, Svyatoslav,
Akhatov, Iskander,
Pavlov, Valentin,
Kzhyshkowska, Julia (2024) about the efficiency of implant integration are done by local resident tissue macrophages and
monocyteLarionova, I.,
Tuguzbaeva, G.,
Ponomaryova, A.,
Stakheyeva, M.,
Cherdyntseva, N.,
V.N. Pavlov,
Choinzonov, E.,
Kzhyshkowska, J. (2020) -specific macrophages and from newly recruited
monocytes. TAMs’ variability strongly depends on cancer type, stage
. Intratumoral TAMs and their precursors, resident macrophages and
monocytes, are principal regulators of tumor
RNAs that are highly expressed in immune cells, including T cells, B cells, NK cells, neutrophils, and
monocytes